TribLIVE

| Business


 
Larger text Larger text Smaller text Smaller text | Order Photo Reprints

Calgon Carbon reaches deal with dissident shareholder

About The Tribune-Review
The Tribune-Review can be reached via e-mail or at 412-321-6460.
Contact Us | Video | Photo Reprints

By Thomas Olson

Published: Tuesday, March 12, 2013, 1:03 p.m.

Calgon Carbon Corp. reached an agreement with a dissident shareholder who was threatening to wage a proxy fight over nominees to the company's board.

The agreement on Tuesday was an apparent win for both sides.

Starboard Value LP, a New York investment firm with a 9.2 percent stake in the company, had sought to elect three outside nominees. The deal calls for the company to add two independent directors to its slate of nominees to be voted on at its annual meeting.

“It's an experienced slate of directors, and this wasn't contentious,” said David Rose, an analyst at Wedbush Securities Inc., Los Angeles. “So, I think both sides win.”

Management agreed to support one of Starboard's nominees, Louis Massimo, former executive vice president and chief operating officer of Arch Chemicals Inc., and one nominee suggested by the board, Donald Templin, senior vice president and chief financial officer of Marathon Petroleum Corp., Calgon Carbon spokeswoman Gail Gerono said.

If the two independent nominees and two others backed by management are elected, Calgon Carbon's board would increase to nine directors from eight. Longtime director Robert Cruickshank will not stand for re-election, the company said.

“It's too early to know what value they will add, but adding directors with an outside perspective and industry perspective is generally beneficial,” Rose said.

The company, which makes air and water purification products, will elect directors at its annual shareholders meeting May 1 at the headquarters in Robinson.

“Both individuals will further strengthen our board with their considerable operational and financial experience,” Calgon Carbon CEO Randy Dearth said in a statement.

“We believe they will make substantial contributions to the company, while serving the best interests of all of its stockholders,” a statement from Starboard CEO Jeffrey Smith said. He declined to elaborate.

Separately, Calgon Carbon amended its shareholder rights plan so that it is not triggered until an acquirer's stake reaches 15 percent, effective immediately. The threshold was 10 percent when the poison pill was adopted in 2005. At the threshold, the board may issue more shares to all but the aggressive acquirer, thereby diluting its stake.

The change gives Starboard room to buy more Calgon Carbon shares. The firm acquired nearly 2.8 million shares for $63.9 million through dozens of stock purchases from Nov. 20 through Jan. 18, according to a securities filing.

Thomas Olson is a staff writer for Trib Total Media; 412-320-7854 or tolson@tribweb.com.

 

 
 


Show commenting policy

Most-Read Business Headlines

  1. Chocolate prices expected to soar as ingredients grow more expensive
  2. Investment in Western Pa. startups reaches 5-year high
  3. Squeezed by competition, Chobani to expand offerings
  4. Pa. unemployment rate falls to lowest since 2008; 12,000 more enter workforce
  5. Under the Hood: A chance to take top cars for a spin
  6. Shale pioneer hires Chesapeake for drilling job
  7. 2014 Beetle is celebration of 65th American anniversary
  8. Long-term unemployed struggle to find — and keep — new jobs
  9. Chrysler’s Easter eggs fun for vehicle owners
  10. Pandora sued by record companies
  11. Mazda recalls 109,000 older SUVs
Subscribe today! Click here for our subscription offers.